IU School of Medicine names new chair to lead Department of Dermatology
IU School of Medicine Aug 23, 2022
INDIANAPOLIS—Indiana University School of Medicine has named a Boston-based physician leader the new chair of the Department of Dermatology.
David Rosmarin, MD, will assume the role of department chair effective January 1, 2023, and will have oversight and responsibility for the program’s clinical, education and research programs.
A highly respected physician-scientist in the field of dermatology, Rosmarin is currently vice chair for research and education at Tufts Medical Center in Boston, Massachusetts, where he serves as an associate professor at the Tufts University School of Medicine.
In addition to his role as vice chair, Rosmarin also currently serves as director of the clinical trials unit in the Department of Dermatology at Tufts—a role in which he has expanded the unit’s focus from psoriasis to also include multiple inflammatory disorders of the skin including atopic dermatitis, hidradenitis suppurativa, vitiligo, alopecia areata, bullous pemphigoid, and discoid lupus erythematosus.
“Dr. Rosmarin’s broad experience in dermatology, clinical research and graduate medical education, make him the ideal candidate for this role,” said Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and IU’s executive vice president for clinical affairs. “We look forward to his leadership to continue building on the department’s patient-centered care and impactful research and education.”
Rosmarin will also hold the Kampen-Norins Scholar appointment. His area of research interest is in inflammatory disorders of the skin and includes leadership of the largest randomized controlled studies ever conducted in vitiligo—a condition in which the skin loses its pigment cells. Along with clinical research, Rosmarin has also held leadership roles in graduate medical education, serving as residency program director from 2016-2020.
He earned his undergraduate and graduate degrees from Harvard University and received his medical degree from New York University School of Medicine in 2005. He completed a preliminary medicine internship at Columbia Presbyterian Hospital and his dermatology residency at Boston and Tufts Medical Centers. He also completed the Tufts Physician Leadership Program at Boston University Questrom School of Business and the Advanced Leadership Forum with the American Academy of Dermatology. He joined the faculty at Tufts University School of Medicine in 2013 as an assistant professor, and was later promoted to associate professor in 2021.
“I am honored by the opportunity to lead the Department of Dermatology and am excited to take on this new challenge. Fostering an environment of inclusion, empowerment, mentorship, innovation, pride, altruism, and compassion is critical to the success of any department, and will lead to continued growth and a thriving, resilient community—these are tenets I am committed to nurturing in this role,” said Rosmarin, who also plans to work to increase diversity in the department.
“There are initiatives that need to be undertaken to improve diversity. Early mentorship and culture are key to this success.”
Rosmarin succeeds Elliot J. Androphy, MD, who announced his intent to step back from his role as chair last year. He will remain with the department to continue his lab research in the development of therapies for human papilloma virus (HPV) and HPV-associated cancers.
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.